AudreyMHamiltonMD

PubMed

• 3 citations
  TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.
  William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, Alison J Moskowitz, Robert N Stuver, Catherine R Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan...> ;Blood Advances. 2023 Sep 12
• 61 citations
  Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.
  Robert Stuver, Gunjan L Shah, Neha S Korde, Lindsey E Roeker, Anthony R Mato, Connie L Batlevi, David J Chung, Sital Doddi, Lorenzo Falchi, Boglarka Gyurkocza, Audrey ...> ;Cancer Cell. 2022 Jun 13
• 1 citations
  Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.
  Fushen Sha, Michelle Okwali, Anna Alperovich, Philip C Caron, Lorenzo Falchi, Audrey Hamilton, Paul A Hamlin, Steven M Horwitz, Erel Joffe, Niloufer Khan, Anita Kumar,...> ;Blood Cancer Journal. 2022 Feb 10
• 39 citations
  Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or ...
  Jacob D. Soumerai, Anthony R. Mato, Ahmet Dogan, Venkatraman E. Seshan, Erel Joffe, Kelsey Flaherty, Jason Carter, Ephraim P. Hochberg, Jeffrey A. Barnes, Audrey Hamil...> ;The Lancet. Haematology. 2021 Dec 1
• 2 citations
  Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.
  Terry K. Pak, Brianne N. Dixon, Michael J Buege, Phuong H. Dao, Megan H. Leary, Joy C. Jarrett, Tara A. Duggan, Philip Caron, Lorenzo Falchi, Paul A. Hamlin, Audrey Ha...> ;Leukemia & Lymphoma. 2021 Nov 16
• 9 citations
  Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring.
  Caitlin Stewart, Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank, Paul A. Hamlin, Matthew J. Matasar, John F. Gerecitano, Pamela Dr...> ;Clinical Cancer Research. 2021 Oct 6
• 69 citations
  Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.
  Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder, Nivetha Ganesan, Esther Drill, Helen Hancock, Theresa Davey, Leslie Perez, Sunyoung Ryu, Samia Sohail, Alayna Santa...> ;Journal of Clinical Oncology. 2021 Jun 25
• 32 citations
  Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse.
  Sabela Bobillo, Erel Joffe, David Sermer, Patrizia Mondello, Paola Ghione, Philip Caron, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Anita Kumar, Matthew J. Ma...> ;Blood Cancer Journal. 2021 Jun 16
• 26 citations
  Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
  Anita Kumar, Carla Casulo, Ranjana H. Advani, Elizabeth Budde, Paul M. Barr, Connie Lee Batlevi, Philip Caron, Louis S. Constine, S.V. Dandapani, Esther Drill, Pamela ...> ;Journal of Clinical Oncology. 2021 Apr 28
• 30 citations
  Clinical Characteristics and Outcomes of Extranodal Stage I Diffuse Large B Cell Lymphoma in The Rituximab-Era
  Sabela Bobillo, Erel Joffe, Jessica A. Lavery, David Sermer, Paola Ghione, Ariela Noy, Philip Caron, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Anita Kumar, M...> ;Blood. 2021 Jan 7
• 8 citations
  Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglobulin Gene Next-Generation Sequencing in a Phase 2 Study of Sequential Chemoradioimmunotherapy Followed by A...
  Anita Kumar, Kurt S. Bantilan, Allison P. Jacob, A. Park, S.F. Schoninger, Craig S. Sauter, Gary A. Ulaner, Carla Casulo, Malek Faham, K.A. Kong, Ravinder K. Grewal, J...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Jan 1
• 59 citations
  Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies.
  David Sermer, Connie L Batlevi, M. Lia Palomba, Gunjan L. Shah, Richard J. Lin, Miguel-Angel Perales, Michael Scordo, Parastoo B. Dahi, Martina Pennisi, Aishat Afuye, ...> ;Blood Advances. 2020 Oct 13
• 8 citations
  Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
  David Sermer, Sabela Bobillo, Ahmet Dogan, Yanming Zhang, Venkatraman E. Seshan, Jessica A. Lavery, Connie Lee Batlevi, Philip Caron, Audrey Hamilton, Paul A. Hamlin, ...> ;Blood Advances. 2020 Jul 28
• 68 citations
  Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
  Connie Lee Batlevi, Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Zhitao Ying, Jacob D. Soumerai, Philip Caron, Lorenzo Falchi, Audrey Hamilton, Paul A. Hamlin, Stev...> ;Blood Cancer Journal. 2020 Jul 17
• 42 citations
  Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
  Sven Borchmann, Erel Joffe, Craig H. Moskowitz, Andrew D. Zelenetz, Ariela Noy, Carol S. Portlock, John F. Gerecitano, Connie Lee Batlevi, Philip Caron, Pamela Drullin...> ;Blood. 2019 May 16
• 52 citations
  Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
  Anita Kumar, Carla Casulo, Joachim Yahalom, Heiko Schöder, Paul M. Barr, Philip Caron, April Chiu, Louis S. Constine, Pamela Drullinsky, Jonathan W. Friedberg, John F....> ;Blood. 2016 Sep 15
• 28 citations
  Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diff...
  David J. Straus, Paul A. Hamlin, Matthew J. Matasar, Maria Lia Palomba, Pamela Drullinsky, Andrew D. Zelenetz, John F. Gerecitano, Ariela Noy, Audrey Hamilton, Rebecca...> ;British Journal of Haematology. 2015 Mar 1
• 54 citations
  Romiplostim for management of chemotherapy-induced thrombocytopenia
  Rekha Parameswaran, M. Lunning, Simon Mantha, Sean M. Devlin, Audrey Hamilton, G. Schwartz, Gerald A. Soff> ;Supportive Care in Cancer. 2014 Jan 12
• 31 citations
  Malignant glomus tumor of kidney: the first reported case and review of literature.
  Gurpreet Lamba, Shamudheen M. Rafiyath, Harneet Kaur, Sameena Khan, Parminder Singh, Audrey Hamilton, Daphne Ang> ;Human Pathology. 2011 Aug 1
• 874 citations
  Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
  Ki Y. Chung, Jinru Shia, Nancy E. Kemeny, Manish A. Shah, Gary K. Schwartz, Archie Tse, Audrey Hamilton, Dorothy Pan, Deborah Schrag, Lawrence H. Schwartz, David S. Kl...> ;Journal of Clinical Oncology. 2005 Mar 20
• 17 citations
  Nonsteroidal and Steroidal Aromatase Inhibitors in Breast Cancer
  Anne Hamilton, Matthew Volm> ;Oncology. 2001 Aug 1
• 14 citations
  Current drug therapy for multiple myeloma
  Yi Wu Huang, Audrey Hamilton, Omar J. Arnuk, Patrick Chaftari, Roy F Chemaly> ;Drugs. 1999 Apr 1
• Primary synovial chondromatosis: a clinicopathologic review and assessment of malignant potential.
  Davis RI, Hamilton A, Biggart JD> ;Hum. Pathol.. 1998-07-01
• Synovial chondrosarcoma complicating synovial chondromatosis. Report of a case and review of the literature.
  Hamilton A, Davis RI, Nixon JR> ;J Bone Joint Surg Am. 1987-09-01
• Pilomatrixoma mimicking breast carcinoma.
  Hamilton A, Young GI, Davis RI> ;Br. J. Dermatol.. 1987-04-01
• Join now to see all

Abstracts/Posters

• High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...
  Audrey Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
  Audrey Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma
  Audrey Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
  Audrey Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all